Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Oligodendroglioma, IDH-mutant and 1p/19q-codeleted grade 2

MONDO:0956996

An IDH-mutant, and 1p/19q-codeleted oligodendroglioma that is characterized as a well differentiated tumor lacking anaplastic features (brisk mitotic activity, microvascular proliferation, necrosis).

2823 clinical trials for this condition and its sub-types, 3 tagged with Oligodendroglioma, IDH-mutant and 1p/19q-codeleted grade 2 itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ IDH-mutant and 1p/19q-codeleted oligodendroglioma (13)

Including sub-types (2823) Tagged with Oligodendroglioma, IDH-mutant and 1p/19q-codeleted grade 2 (3)

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Brain tumor drug vorasidenib tested in everyday practice

Disease control Ongoing

This study looks at how well the drug vorasidenib works and how safe it is for people with a slow-growing type of brain tumor called grade 2 astrocytoma or oligodendroglioma that has an IDH1 or IDH2 mutation. The study includes people aged 12 and older in China who are treated in…

Sponsor: Servier (Tianjin) Pharmaceutical Co. LTD. • Aim: Disease control

Last updated Jul 23, 2026 00:00 UTC